Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xylometazoline vs Cocaine for Epistaxis in Nasal Intubation
NCT05334017Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Sep 2022
- Primary completion
- Mar 2023
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of xylometazoline, cocaine in epistaxis, sponsored by Rigshospitalet. Started Sep 2022; status: completed.
02
Drugs
xylometazolinecocaine
03
Conditions
epistaxis
Beyond the preview
Go deeper on NCT05334017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05334017.